Featured Items
The AI-Enabled Toxicologic Pathologist: A Day with Foresight 2.0
Join us for this 30-minute webinar where we take you inside the day of a toxicologic pathologist working with AI.
How Patholytix Accelerates Study Timelines in Research
Pharmaceutical R&D runs on precision, but speed is what separates discovery from delivery.
From Glass Slides to Strategic Data: How Patholytix Scanning Powers Research at Scale
In pharmaceutical R&D, glass slides represent one of the most valuable yet underleveraged assets. These physical records contain decades of study insights, histological patterns, and high-stakes decisions.
All Resources
Reinventing Slide Management in Research Pathology with Patholytix
The modern pharmaceutical research environment is awash with data, yet the management of one of its most critical assets (pathology slides) remains stubbornly inefficient.
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the next phase of a strategic collaboration to focus on advancing cutting-edge image management solutions
Deciphex Launches Diagnexia Analytix: Revolutionising Pathology Services for Translational Research and Development with Advanced AI-Driven Insights
Patholytix, the research pathology division of Deciphex, proudly announces the launch of Diagnexia Analytix, a comprehensive pathology service offering that integrates advanced analytics and AI-powered workflows with expert-led diagnostics to elevate study outcomes.
Deciphex Secures €31M Series C to Address Global Pathology Shortage
Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising €31 million to address the acute global pathology crisis.
Foresight: Enhancing Toxicologic Pathology with AI Decision Support - Through Pathologists Insights.
Join us for this 60-minute webinar where we explore the impact of AI on toxicologic pathology.
Launch of IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls
Deciphex today announced the launch of VICT3R, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation
Patholytix 4.0, Becomes First Platform to Support Future-proof Study Archival of Regulated Digital Safety Studies
Deciphex, a pioneering leader in GLP-compliant digital pathology solutions, announces today that it is the first DICOM-native platform to fully facilitate the archival and reconstruction of regulated digital studies. Previously unavailable, this advancement strengthens digital pathology's use in GLP drug safety assessment.
Deciphex Enters into Collaboration Agreement with Novartis to Advance AI in Preclinical Studies
Collaboration Agreement Seeks to engage AI to Transform Non-clinical Pathology Assessments in Drug Discovery and Development
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Powered by digital pathology and AI algorithms, Patholytix Foresight drives speed and quality in toxicologic pathology practices
Deciphex Announce Web Based Enhancements to Patholytix, Enabling Any Time, Anywhere Peer Review
With the release of Patholytix 4.0, Deciphex introduces a new workflow, enabling users to access the platform through the web.
Introducing Foresight: A Unique Decision Support AI Tool For The Bench Toxicologic Pathologist
Discover the future of digital pathology at our exclusive webinar, featuring the launch of 'Foresight' within Patholytix 4.0.
Webinar: Do More in 24 with Patholytix 4.0
Watch the launch of Patholytix 4.0 launch event
Deciphex Enables First Digital GLP Peer Review Conducted by a Consultant for a Contract Research Provider
In 2023, a Toxicological Pathologist at Integrated Biologix GmbH, Sarah Taplin, became the first consultant pathologist to perform a regulated digital peer review for a study conducted at a drug development research provider.
Webinar: Unlocking Efficiency and Precision: Simplify Your Non-Clinical Pathology Workflow with the Patholytix Data Capture Module
Join us for the inaugural session of our Superuser Webinar Series, where we shine a spotlight on the game-changing Patholytix Data Capture Module (DCM).
Synergies and Challenges in the Preclinical and Clinical Implementation of Pathology Artificial Intelligence Applications
Deciphex and Xybion Digital join forces to Infuse the Power of Micropathology Digital Slide Reading into Dynamic Non-clinical Study LIMS Workflows
Deciphex, a trailblazer in digitizing and networking global pathologists, has joined forces with Xybion, a global leader in unified cloud software solutions for regulated industries.
Deciphex Accepted into MHRA GLP Monitoring Programme and Imminent Attainment of GLP Certification at Exeter Site
Deciphex, a pioneering leader in digital pathology solutions, is pleased to announce the acceptance of, Diagnexia UK Limited, into the Medicines and Healthcare products Regulatory Agency (MHRA) GLP Monitoring Programme as a prospective member, and the expected achievement of Good Laboratory Practice (GLP) compliance statement for its cutting-edge facility located in Exeter.
AI Helps Pathologists Be More Certain Sooner
Digitisation and artificial intelligence is affecting how fast lifesaving drugs are developed
It's Time to End the Systemic Delays of Lifesaving Drugs
Digitisation and artificial intelligence is affecting how fast lifesaving drugs are developed
Mitotic Figure Detection in Rat Liver Using Supervised Deep Learning Based Object Detection Models
Webinar: Streamlining the Process of Reviewing Preclinical Studies with Digital Solutions
Are you tired of the slow and cumbersome process of reviewing preclinical studies via non-digital methods?
Deciphex Completes Validation Activities Enabling Veterinary Consultant Pathologists To Perform GLP Peer Review Digitally Using Patholytix
This major advance means that veterinary consultant pathologists can work entirely in the digital domain and maintain GLP-compliance throughout a peer review.
Faster Study Delivery With Patholytix Automated Image QC
By building Automated Image QC into Patholytix 3.0, Deciphex delivers dramatically faster turnarounds of studies.
Patholytix Introduces Digital Pathology Review And Scoring In A Single Platform For The First Time
With Patholytix 3.0, Deciphex overcomes one of the last barriers to full-scale adoption of digital pathology.
Webinar: Meet the Tech That Accelerates Critical Decisions in Drug Safety Assessment
Learn how Patholytix DCM can help you make critical decisions on drug candidates more efficiently, accelerating your journey to market.
Webinar: Give Us 60 Minutes and We’ll Save You Hours. And Hours. And Hours.
In this 1-hour webinar, our Director of AI Services, Trevor McKee, will show how automated image quality control now alleviates significant workload pressures on technicians and pathologists alike.
Metric-Based Validation of WSI Scanner Color and Quantitative Standardization for Pathologists and AI
Patholytix Validated for GLP Primary and Peer Review
Reduces Time and Cost of Safety Assessment Studies.
The Development of Deep Learning-Based Classifiers for Pathologist Decision Support in Evaluation of Short Term Rodent Toxicology Studies
Using AI Based Nuclear Segmentation to Infer Toxicologic Pathology Outcomes such as Liver Hypertrophy from Cell Density Maps
Webinar: Using Patholytix AI to Identify Signs of Drug Toxicity in Preclinical Safety Assessment Studies
Join us for our webinar on Wednesday, July 27th, on the topic “Using Patholytix AI to Identify Signs of Drug Toxicity in Preclinical Safety Assessment Studies”.
Deciphex Presents Poster at STP 2022 - “Using AI Based Nuclear Segmentation to Infer Toxicologic Pathology Outcomes such as Liver Hypertrophy from Cell Density Maps”
This week we were thrilled to get the opportunity to present our poster on the topic “Using AI Based Nuclear Segmentation to Infer Toxicologic Pathology Outcomes such as Liver Hypertrophy from Cell Density Maps”.
Deciphex Enables Digital Pathology Primary Review for GLP Studies
Deciphex have announced today that they are first in industry to offer clients Good Laboratory Practice (GLP) compliant digital primary review.
Deciphex at SFPT Congress 2022
Deciphex is participating in the French Society of Toxicological Pathology (SFPT) Congress 2022 in Toulouse, from the 19th - 20th of May.
Deciphex Launch Fully Outsourced AI Services for Non-clinical Digital Pathology
Deciphex have announced today that it is now a full service provider in Pathology AI and Quantitative Pathology.
Deciphex Appoints Dr. Trevor McKee to Spearhead Quantitative Pathology and Artificial Intelligence Service Delivery in Research Pathology
Deciphex announce that it has appointed Dr. Trevor McKee as Director of Commercial AI Services for Research Pathology to spearhead this exciting initiative.
Deciphex at Society of Toxicology (SOT) 61st Annual Meeting and ToxExpo
Deciphex is exhibiting at the Society of Toxicology (SOT) 61st Annual Meeting and ToxExpo happening in San Diego, California, from the 27-31st of March.
Deciphex Announce the Release of New Service Which Enables Veterinary Consultant Pathologists to Easily Onboard Digital Studies from their Partners via Patholytix Preclinical
Deciphex have introduced a new service to facilitate on-demand sharing of studies with any veterinary consultant pathologist on a pay-per-use basis with zero cost to the consultant.
Deciphex at Digital Pathology & AI Conference 2022
Our Director of Commercial AI Services for Research Pathology, Trevor Mc Kee will be speaking at the Digital Pathology & AI Conference 2022 happening virtually, from the 24-25th of March.
Utilizing Whole Slide Images for the Primary Evaluation and Peer Review of a GLP-Compliant Rodent Toxicology Study
The approach undertaken to deliver a Good Laboratory Practice (GLP) validation of whole slide images (WSIs) and the associated workflow for the digital primary evaluation and peer review of a GLP-compliant rodent inhalation toxicity study is described.
Experience Patholytix at the Cutting Edge Pathology Virtual Congress this Month
Deciphex are pleased to announce our Gold Sponsorship of the 4th ESVP, ECVP and ESTP Cutting Edge Pathology Congress taking place on the 15th-17th of September.
Deciphex are delighted to announce the launch of Patholytix Preclinical 2.1
This latest release of our award winning digital pathology platform delivers significant workflow improvements for our users and provides even greater support for early stage research applications through the introduction of Quantitative Pathology.
Evaluation of the Use of Single- and Multi-Magnification Convolutional Neural Networks for the Determination and Quantitation of Lesions in Nonclinical Pathology Studies
Detecting Secondary Follicles in the Spleen and Lymph Nodes : An Exploratory Study Case to Compare Image Analysis on IHC Slides Versus AI based Detection on H&E Stained Slides
Development of a Novel AI-Based Algorithm for Abnormality Detection in the Testes of Rats
Developing a Deep Learning Convolutional Neural Network Method to Detect Non-Human Primate Skin Lesions
Developing a Deep Learning Convolutional Neural Network Method to Detect Small Intestine Pathology in Rat Ileum
Development of a Deep Learning Method for Bronchoalveolar Lavage Fluid (BALF) Analysis
Deciphex Delivers Industry-first Patholytix Digital Pathology Peer Review for GLP Studies in Partnership with Charles River Laboratories
Deciphex and Charles River Laboratories International, Inc. (NYSE: CRL) have jointly announced today that they are the first in the industry to offer clients Good Laboratory Practice (GLP) validated digital peer review, using Deciphex Patholytix Preclinical for toxicologic pathology.
Using Deep Learning Artificial Intelligence Algorithms to Verify N-Nitroso-N-Methylurea and Urethane Positive Control Proliferative Changes in Tg-RasH2 Mouse Carcinogenicity Studies
Deciphex launch Patholytix Preclinical 2.0 enabling GLP Digital Pathology Peer Review
At Deciphex our mission is to enable our users to facilitate digital peer review of non-clinical pathology studies. We are delighted to announce the upcoming launch of Patholytix Preclinical 2.0 which provides our clients with a pathway to a regulated GLP Peer Review in conjunction with their CRO partners.
PODCAST: How Deciphex is Accelerating the Non-clinical Drug Development Phase - Interview with Aleksandra Zuraw
Our CEO Donal O’Shea featured on the Digital Pathology Space’s podcast hosted by Aleksandra Zuraw this week to discuss how Deciphex is accelerating the non-clinical drug development phase.
Deciphex are delighted to announce the launch of Patholytix AI 1.5
To mark the recent launch of Patholytix AI 1.5, we describe how Patholyix AI fits in the technology landscape available to AI developers working on Pathology AI projects, and how the platform can benefit them in accelerating impactful data generation for their pathology stakeholders.
Patholytix Preclinical 1.4 with Work from Home Mode
We understand that many of our partners now face changing work practices and are more reliant now than ever on remote collaborative tools to manage their day to day operations. Our team remains as committed and as capable as ever to supporting you, and to help you protect business continuity.
Deciphex open US office in Chicago, Implement high throughput scanning service for clients.
Deciphex are delighted to announce the opening of its first US Facility as part of our planned US expansion. The facility in Naperville will be a scanning and research centre, to support our collaboration with GI Partners of Illinois and to provide valuable scanning capacity for our pharma and research clients.
Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development with Digital Pathology
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a partnership with Deciphex, a leader in preclinical digital pathology software-as-a-service.
Development of a Deep Learning Method for Discriminating Anterior Nasal Cavity Degenerative, Regenerative, and Inflammatory Lesions in the Rat
Deep Learning AI Provides Decision Support For Pathologists Through Abnormality Detection in the Rat Anterior Nasal Cavity
Global Engage - Digital Pathology Conference UK 2019
Consortium partners Janssen and Deciphex both attended and presented at the 6th Annual Global Engage Digital Pathology and AI congress in London on the 5th of December 2019.
PATHTOX 1st Annual review meeting
A 1st-year review meeting was conducted with all consortium partners in London in December 2019 prior to the annual global engage conference.
PATHTOX at ESTP 2019
The 17th European Congress of Toxicologic Pathology was held at the Maternushaus in Cologne, Germany
PATHTOX On-Site Workshop
A round table meeting was organised between the Deciphex team and various members of the pathology, quality & regulatory and statistical departments of Janssen, to introduce the project to the internal team in Janssen.
Deep Learning Enables Screening for Tumor Positive and Negative Tg-rasH2 Mice in Positive Control Groups at 100% Concordance with Toxicologic Pathologists
High Performance AI Based Image Segmentation of Tissues and Organs in Preclinical Toxicologic Rat Studies
Development and Validation of an Optimal Digital Pathology Workflow for Toxicologic Pathology
Automated Artificial Intelligence (AI) Whole Slide Image Analysis Of Wistar Rat Livers as a Support Tool for Toxicologic Pathologists
Kickoff meeting for PATHTOX FTI project
A kick-off meeting was held in London which Deciphex, Janssen and PDS attended.
See Patholytix in Action
Every team uses Patholytix a little differently. Speak with our team today to understand how Patholytix can help you unlock your research data.
